VUE panels for multiplex immuno-fluorescence

Adapted from a line in “Ode to a Mouse” from Robert Burns, the phrase, “the best-laid plans of mice and men often go awry”, indicate that no matter how carefully a project is planned, something may still go wrong with it unfortunately speaks to the reality of clinical trials for novel therapeutics, with approximately only 11% of drugs that begin phase I clinical trials eventually being licensed.

I have learned in my career that there is a special recipe for making young companies successful. You need to have an amazing product that enables customers to accomplish their goals in a better way than their current method. You need to have a product that can evolve with the needs of the customer, and in our case, with the biology.

It is clear that “zoom fatigue” has set in, and some of the novelty of virtual conferences has worn off in the past year; having said that, they are likely here to stay, even as in-person events return with hybrid events in 2022.

It’s clearly a very timely discussion with many recent articles reviewing the complexities of the tumor microenvironment and overall tumor heterogeneity that have been implicated in late-stage clinical failures, underscoring an urgent need for tests that accurately predict response to the growing number of available therapies.

Growing up I was fascinated by the early black and white psychological crime dramas by the master of suspense, Alfred Hitchcock. Several unique components played their part in his success as director; his ability to keep the story simple noting that the screenplay should be streamlined, so it offers the highest dramatic impact.